KG

Kamlesh Gangwar

Active Director Director DIN 11927519
DIN 11927519 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamlesh Gangwar

Kamlesh Gangwar is a Director at Santirion Pharmaceuticals Private Limited (since 2026).

DIN 11927519
Primary Designation Director
First Appointment 04 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20262026Active

Board colleagues of Kamlesh Gangwar

NameDINCompanyDesignation
Pawan Kumar SharmaSantirion Pharmaceuticals Private LimitedIndividual Subscriber
Sarvjeet PatelSantirion Pharmaceuticals Private LimitedIndividual Subscriber
Vaishali GangwarSantirion Pharmaceuticals Private LimitedIndividual Subscriber
Vimal Prakash11927520Santirion Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Santirion Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kamlesh Gangwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamlesh Gangwar

Kamlesh Gangwar currently holds 1 directorship: Santirion Pharmaceuticals Private Limited (Director, since 04 Sep 2026).

Kamlesh Gangwar was first appointed on 04 Sep 2026 as Director at Santirion Pharmaceuticals Private Limited.

The current boards of Kamlesh Gangwar's companies include Pawan Kumar Sharma (Santirion Pharmaceuticals Private Limited), Sarvjeet Patel (Santirion Pharmaceuticals Private Limited), Vaishali Gangwar (Santirion Pharmaceuticals Private Limited), Vimal Prakash (Santirion Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available